The composite wound dressing apparatus promotes healing of a wound via the use of a vacuum pump. The vacuum pump applies a vacuum pressure to the wound to effectively draw wound fluid or exudate away from the wound bed. The vacuum pump is tethered to the wound dressing and is portable, preferably, carried by the patient in a support bag, which permits patient mobility. Moreover, the patient does not need to be constrained for any period of time while exudate is being removed from the wound.

An elongate wound dressing for packing a wound is substantially planar and has a first longitudinal edge comprising at least one curved edge portion which is curved in the plane of the wound dressing.

The invention provides a process for producing polyurethane foams, the foams thus produced and the uses thereof. In the inventive process compositions comprising A) isocyanate-functional prepolymers obtainable by the reaction of A1) aliphatic, low molecular weight diisocyanates of molar mass from 140 to 278 g/mol with A2) polyalkylene oxides having an OH functionality of two or more, A3) optionally further isocyanate-reactive components not covered by A2), B) water in an amount of at least 2% by weight, based on the total weight of the composition; C) optionally heterocyclic 4-membered or 6-membered ring oligomers of low molecular weight, aliphatic diisocyanates having a molar mass of 140 to 278 g/mol; D) optionally catalysts; E) optionally salts of weak acids, the corresponding free acids of which have a pKA in water at 25? C. of ?3.0 and ?14.0; F) optionally surfactants; G) optionally mono- or polyhydric alcohols or polyols, and H) optionally hydrophilic polyisocyanates obtainable by reaction of H1) low molecular weight, aliphatic diisocyanates of molar mass from 140 to 278 g/mol and/or polyisocyanates preparable therefrom and having an isocyanate functionality of 2 to 6 with H2) monofunctional polyalkylene oxides of OH number from 10 to 250 and of ethylene oxide content from 50 to 100 mol %, based on the total amount of the oxyalkylene groups present,
are provided, foamed and cured, wherein the isocyanate-containing components, especially components A), C) and H), have a total isocyanate content within a range from 2% to 8% by weight and a content of urethane groups of 1.0 to 3.5 mol/kg, based in each case on the total amount of the isocyanate-containing components.

The invention provides a process for producing polyurethane foams, the foams thus produced and the uses thereof. In the inventive process compositions comprising A) isocyanate-functional prepolymers obtainable by the reaction of A1) aliphatic, low molecular weight diisocyanates of molar mass from 140 to 278 g/mol with A2) polyalkylene oxides having an OH functionality of two or more, A3) optionally further isocyanate-reactive components not covered by A2), B) water in an amount of at least 2% by weight, based on the total weight of the composition; C) optionally heterocyclic 4-membered or 6-membered ring oligomers of low molecular weight, aliphatic diisocyanates having a molar mass of 140 to 278 g/mol; D) optionally catalysts; E) optionally salts of weak acids, the corresponding free acids of which have a pKA in water at 25 C. of 3.0 and 14.0; F) optionally surfactants; G) optionally mono- or polyhydric alcohols or polyols, and H) optionally hydrophilic polyisocyanates obtainable by reaction of H1) low molecular weight, aliphatic diisocyanates of molar mass from 140 to 278 g/mol and/or polyisocyanates preparable therefrom and having an isocyanate functionality of 2 to 6 with H2) monofunctional polyalkylene oxides of OH number from 10 to 250 and of ethylene oxide content from 50 to 100 mol %, based on the total amount of the oxyalkylene groups present,
are provided, foamed and cured, wherein the isocyanate-containing components, especially components A), C) and H), have a total isocyanate content within a range from 2% to 8% by weight and a content of urethane groups of 1.0 to 3.5 mol/kg, based in each case on the total amount of the isocyanate-containing components.

The invention relates to an absorbent article for application to human or animal skin surfaces in the region of wounds, consisting of an outer covering (2) which is permeable for liquid substances, and of an inner layer (1) which is surrounded by the covering (2) and which consists essentially of a mixture of an amount of strongly osmotically active substances with an amount of osmotically comparatively weak or osmotically inactive substances, such as cellulose. The inner layer (1) is filled with osmotically active substances in such a way that it is possible to exert on a wound, with the wound fluids contained therein, an osmotic pressure via which the wound fluid can be removed from the organism to be treated, and thus it is possible to assist both in the surfaced wound region and in the depth of the tissue a normal interstitial hydration of tissue by directing endogenous fluids in their direction of flow to the patient's skin surface into the absorbent article, and keeping them there.

Body-fluid containers, methods, and systems are presented that include a container that has a container housing formed, at least in part, by a liquid-impermeable, vapor-permeable material. The liquid-impermeable, vapor-permeable material allows water to evaporate and be transmitted outside of the container. The evaporation allows more fluid to be processed by the container than the container could otherwise hold. Other systems, methods, and apparatuses are presented.

A dermal patch includes: an open-cell foam layer; and an adhesive layer arranged thereon and intended for contact with skin. At least a side of the foam layer facing the adhesive layer has macropores whose cavities are spanned at least partially by a barrier layer formed from the foam layer.

Body-fluid containers, methods, and systems are presented that include a container that has a container housing formed, at least in part, by a liquid-impermeable, vapor-permeable material. The liquid-impermeable, vapor-permeable material allows water to evaporate and be transmitted outside of the container. The evaporation allows more fluid to be processed by the container than the container could otherwise hold. Other systems, methods, and apparatuses are presented.

Dressings, systems, and methods for treating a tissue site on a patient involve allowing liquids from the tissue site or a priming fluid to evaporate and exit the dressing through a liquid-impermeable, vapor-permeable membrane. The dressing is able to process more liquids than would otherwise be possible without evaporation and potentially to create reduced pressure. Other dressings, systems, and methods are disclosed.

The invention relates to a vacuum treatment array having at least one open-pored contact element, by way of which a negative pressure and/or suction can be generated in a body cavity, wherein the open-pored contact element is configured, at least in sections, in the manner of a tube, having an outer and/or inner boundary surface rotating around a tube axis, at least in part.